Late-onset NPM1 mutation in a MYC-amplified relapsed/refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib

Jaramillo, Sonia; Scherer, Michael; Szu-Tu, Chelsea; Beneyto Calabuig, Sergi; Müller-Tidow, Carsten; Schlenk, Richard F.; Hundemer, Michael; Velten, Lars; Pabst, Caroline

doi:http://dx.doi.org/10.3324/haematol.2023.284922

Late-onset NPM1 mutation in a MYC-amplified relapsed/refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib

License

Citation

Jaramillo S, Scherer M, Szu-Tu C, Beneyto-Calabuig S, Müller-Tidow C, Schlenk RF, et al. Late-onset NPM1 mutation in a MYC-amplified relapsed/refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib. Haematologica. 2024 Nov 1;109(11):3811-5. DOI: 10.3324/haematol.2023.284922